From discovery to approval: mapping the global health R&D pipeline
An end-to-end interactive view of the global health R&D pipeline, from investigational candidates to approved products reaching people in need.
Scale of R&D by global health area
Toggle views: Candidates in development | Approved products
This bubble chart shows the relative scale of the product development landscape across global health areas. Each bubble represents a global health area, with its size indicating the number of products in scope. Use the dropdown menu to switch between candidates in development and approved products to compare where R&D activity and market-ready solutions are most concentrated.
Geographic distribution of clinical trials and developers
A global snapshot of R&D activity, highlighting where clinical trials are conducted and where product developers are based.
This global heat map illustrates where R&D activity is concentrated across countries. Use the tabs to switch between the location of clinical trials and the location of developers. Darker shades indicate countries with a higher concentration of trials or developers, highlighting global research hubs as well as regions with limited R&D presence.
Portfolio overview by global health area
Explore portfolio analysisA cross-section of the R&D pipeline by global health area and development stage. Each horizontal bar represents a global health area, with colour-coded segments showing the number of candidates and approved products. Use the filters below to focus on specific product types or R&D stage. Click items in the legend to turn individual stages on or off to compare how pipelines are distributed across the development lifecycle.
Cross-pipeline analytics
Make custom comparisonA high-level view of how the global R&D pipeline evolves over time across development stages. This chart shows changes in the number of candidates in early development, late development and approved products across IGH review years. Use the filters to focus on a specific global health area or product type. Click on the legend to turn individual development stages on or off to compare how the pipelines are progressing through the R&D lifecycle over time.
Reports and insights
View all insightsDiscover the insights that two decades of global health data have given us.
The Ripple Effect 2.0: from global health to domestic value
Executive briefing presenting findings from three case studies demonstrating how selected global health innovations enhance health outcomes and provide economic value across the US, UK, Japan, and Europe.
Read more-404x404.webp)
100 Days Mission: 5th Implementation Report and Scorecard
The 100 Days Mission's 5th Implementation Report and Scorecard highlight limited progress has been made in an R&D ecosystem that remains reactive and reliant on US funding.
Read more